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Summary
Small RNAs regulate genetic networks through a ribonucleo-
protein complex called the RNA-induced silencing complex
(RISC), which, in mammals, contains at its center one of
four Argonaute proteins (Ago1–Ago4) (reviewed in [1–4]). A
key regulatory event in the RNA interference (RNAi) and
microRNA (miRNA) pathways is Ago loading, wherein
double-stranded small-RNA duplexes are incorporated into
RISC (pre-RISC) and then become single-stranded (mature
RISC), a process that is not well understood [5, 6]. The Agos
contain an evolutionarily conserved PAZ (Piwi/Argonaute/
Zwille) domain [7, 8] whose primary function is to bind the
30 end of small RNAs [9–13]. We created multiple PAZ-
domain-disrupted mutant Ago proteins and studied their
biochemical properties and biological functionality in
cells. We found that the PAZ domain is dispensable for
Ago loading of slicing-competent RISC. In contrast, in the
absence of slicer activity or slicer-substrate duplex RNAs,
PAZ-disrupted Agos bound duplex small interfering
RNAs, but were unable to unwind or eject the passenger
strand and form functional RISC complexes. We have dis-
covered that the highly conserved PAZ domain plays an
important role in RISC activation, providing newmechanistic
insights into how miRNAs regulate genes, as well as new
insights for future design of miRNA- and RNAi-based
therapeutics.
Results and Discussion
Ago2 Lacking the PAZ Domain Retains the Ability to
Associate Small RNAs and Elicit Noncleavage Gene
Repression
We investigated the role of the PAZ (Piwi/Argonaute/Zwille)
domain by creating a truncated Ago2 with a complete PAZ-
domain deletion (Ago2-DPAZ) (Figure 1A). We measured the
association between the truncated Ago2-DPAZ and small
RNAs processed from small hairpin RNAs (shRNAs) using
immunoprecipitation (IP) assays. Specifically, two U6-driven
shRNAs (sh-miR30 and sh-miR30-B), designed to generate
the same guide strand as that derived from the endogenous
hsa-miR30a-3p microRNA (miRNA) but having differing stem
structures and thermodynamic stabilities [14], were coex-
pressed with various Flag-tagged Ago2 variants or a control
Flag-green fluorescent protein (GFP) expression cassette in
Ago2 knockout (KO) mouse embryonic fibroblast (MEF) cells
[15] (Figure 1B). Western blot experiments established that
the Flag-tagged version of Ago2 and the truncated mutant2These authors contributed equally to this work
*Correspondence: markay@stanford.edu(Ago2-DPAZ) were expressed at nearly equivalent amounts
in MEF cells (Figure 1C). Quantification of the sh-miR30 or
sh-miR30-B RNAs bound to each of the Ago2 variants was
determined 24 hr posttransfection by anti-Flag IP and northern
blotting. The Ago2 variant pull-down results were confirmed to
be Ago-specific because of the lack of signal in the GFP pull-
down control (Figure 1B). Interestingly, deletion of the PAZ
domain did not abolish the interaction between Ago2 and
small RNA, as IP experiments showed that Ago2-DPAZ was
able to bind the guide-strand RNA (derived from sh-miR30
and sh-miR30-B), albeit at a reduced level compared to the
wild-type (Figure 1B).
In Ago2 KO cells, cleavage-based gene silencing is abol-
ished, but residual small interfering RNA (siRNA)- or shRNA-
induced gene silencing through noncleavage repression is
detectable due to the presence of Ago1, Ago3, and Ago4
[14–16]. Nevertheless, the noncleavage repression specifically
mediated by the Ago2 mutants can be determined via comple-
mentation experiments in these cells. To do this, we utilized
well-characterized reporter systems in which four tandem
target sites were inserted into the 30 untranslated region
(UTR) of the Renilla (RL)-luciferase reporter gene (Figure 1D).
Sh-miR30 and sh-miR30-B generated the same guide strands
that were mismatched to reporter psi-4x-miR30-M, providing
a means to measure the noncleavage repression. Concordant
with the small-RNA association results, Ago2-DPAZ demon-
strated a substantial (p < 0.0001) albeit reduced amount of
gene repression compared to wild-type Ago2 (Figure 1D), in-
dicating that the truncated Ago2 without a PAZ domain
retained its ability to associate with small RNAs and to silence
genes. This conclusion was confirmed with a second shRNA
sequence based on Drosophila bantam miRNA (Figure S1
available online).
HsAgo2 Slicer Activity Is Retained with Deletion of the PAZ
Domain
Although the Ago2-DPAZ retained the ability to silence
mismatched targets through noncleavage repression, we
wanted to investigate whether the PAZ deletion affected the
slicer activity. To directly measure the slicer activity of Ago2-
DPAZ, we performed an in vitro cleavage assay using a
radioactive-labeled RNA target perfectly matched to the guide
strand of sh-miR30 and sh-miR30-B. As shown in Figure 1E,
a substantially lesser amount of cleavage product was de-
tected in the sample treated with Ago2-DPAZ compared to
that of wild-type Ago2, demonstrating that Ago2-DPAZ had
weak slicer activity. The remaining cleavage activity was con-
firmed to be Ago2-DPAZ-specific because of the total absence
of signal in the Ago2-D5 control (Figure 1E). At this point, it was
unclear whether the reduction in cleavage activity was due to
impairment of inherent slicer activity, a result of less-efficient
binding between Ago2-DPAZ and guide-strand RNA, or both.
Nonetheless, the cleavage product of Ago2-DPAZ was the
same size as that of wild-type Ago2 (Figure 1E), establishing
that the cleavage process mediated by Ago2-DPAZ was still
precise, which implies that deletion of the PAZ domain did
not disrupt the ternary complex of the protein, guide strand,
and target RNA [17].
Figure 1. Truncated Ago2 without the PAZ Domain Can Associate Small RNAs, Elicit Noncleavage Gene Repression, and Slice Target RNA
(A) Schematic representation of human Ago2 and its Flag-tagged truncated version lacking the PAZ domain.
(B) Perfect-stem sh-miR30 or bulged-stem shRNA-miR30-B coexpressed with Flag-GFP (negative control), Flag-Ago2, or its mutants in Ago2 KOMEF cells.
24 hr posttransfection, IP experiments with anti-Flag antibody were performed on cell lysates. RNA extracted from either 20%of input or IPwere run on 15%
polyacrylamide 7 M urea denaturing gels. Guide- and passenger-strand RNAs from each sample were identified by sequential northern blotting. The inten-
sity of the bands was determined by phosphoimaging. The pull-down efficiency listed in the figure was calculated by dividing the IP signal with total input.
(C) Cell lysates were also subjected to a western blot using Ago2 antibody. Wild-type Ago2, Ago2-DPAZ, and Ago2-D5 were expressed at similar levels. The
signal from endogenous GAPDH served as the loading control.
(D) PsiCHECK vectors with four tandem target sites in the 30 UTR, which were mismatched to the guide strand of sh-miR30 and sh-miR30-B, were cotrans-
fected with various shRNAs in Ago2 KO MEF cells. Dual-luciferase assays were performed 24 hr posttransfection. RL-luciferase activities were normalized
with Firefly (FF)-luciferase, and the percentage of relative enzyme activity compared to the negative control (treated with sh-scramble) was plotted. Error
bars represent the SD from two independent experiments, each performed in triplicate transfections.
(E) The cleavage activities of the wild-type human Ago2 and the mutant derivatives were measured with an in vitro cleavage assay. Target RNA was
incubated with 32P-labeled sh-miR30 guide-strand RNA and IP-derived Argonaute proteins at 26C for 90 min. Products of the cleavage reaction were
purified, separated, and detected by autoradiography. The expected size of 50 cleavage products is 27 nucleotides (nt) as indicated in the figure. The inten-
sity of the bands was determined by phosphoimaging as shown in the figure (the Ago2-treated sample was assigned a value of 100). A nonspecific band is
labeled with # and was not observed in a repeat experiment. See also Figure S1.
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1537The PAZ Domain Is Required for HsAgo1, HsAgo3, and
HsAgo4 to Unwind Small-RNA Duplexes during RISC
Activation
Consistent with the role of the PAZ domain in small-RNA asso-
ciation, fewer guide and passenger strands processed from
sh-miR30 and sh-miR30-B were pulled down with trun-
cated, noncleaving Agos (Ago1-DPAZ, Ago3-DPAZ, and
Ago4-DPAZ [Ago1/3/4-DPAZ]) than were obtained with their
wild-type counterparts (Figure 2A).
Interestingly, Ago1/3/4-DPAZ mutants were almost com-
pletely unable to induce transgene silencing in the functional
assay, despite the fact that substantial amounts of guide
strands from sh-miR30 and sh-miR30-B were detected in the
respective Ago pull-down experiments (Figures 2A and 2B).
Specifically, overexpression of Flag-tagged Ago1/3/4-DPAZcaused no increase in the repression activity of both
sh-miR30 and sh-miR30-B (Figure 2B). Similar results were
observed with sh-Bantam (Figure S2).
We established previously that noncleavage Agos (Ago1/
3/4) failed to generate sufficient amounts of active RISC with
stable sh-miR30 because of the inefficiency of the unwinding
step [14]. Thus we hypothesized that Ago1/3/4-DPAZ were
incapable of unwinding an associated duplex RNA. To directly
test this idea, we analyzed the same Ago-IP samples using
a native gel that provides a means to distinguish between
Ago-associated single-stranded and duplexed RNAs [14].
The stable, less active sh-miR30 RNAs associated with
noncleaving Agos (Ago1/3/4) were almost exclusively found
as duplexes, whereas the less stable but more active
sh-miR30-B RNAs associated with the noncleaving Agos
Figure 2. The PAZ Domain Is Required for
HsAgo1, HsAgo3, and HsAgo4 to Form Mature
RISC
(A) Sh-miR30 or shRNA-miR30-B coexpressed
with Flag-GFP or various Flag-Agos and their
mutants in Ago2 KO MEF cells. IP and northern
blotting experiments were performed as de-
scribed in Figure 1. The expression levels of the
proteins used in the assays were assessed by
western blotting with anti-Flag antibody and are
shown in the lower panel.
(B) A psiCHECK vector with four tandem target
sites in the 30 UTR, which were mismatched to
the guide strand of sh-miR30 and sh-miR30-B,
was co-transfected with various shRNAs and
Argonaute-expressing plasmids in Ago2 KO
MEF cells. Dual-luciferase assays were per-
formed and analyzed as described in Figure 1.
Error bars represent the SD from two indepen-
dent experiments, each performed in triplicate
transfections.
(C) IP samples in (A) were separated on 15%
polyacrylamide native gels. 20 fmol synthetic
si-miR30 duplex was also loaded on the gel
as a control. Guide- and passenger-strand RNAs
were identified by sequential northern blot.
Notably, the si-miR30 control ran as a mixture
of dsRNA and a trace amount of ssRNA. See
also Figure S2.
Current Biology Vol 22 No 16
1538were more prominently found as single-stranded guide-
strand RNAs (Figure 2C). In contrast to the differences
between sh-miR30 and sh-miR30-B, virtually all of the guide
and passenger strands from both shRNAs found to be
associated with the PAZ-deletion mutants were present as
duplex-RNA forms (Figure 2C). These results strongly suggest
that the RISC activation is dependent on the PAZ domain;
in the absence of the PAZ domain, RISC is unable to un-
wind even thermodynamically unstable small-RNA duplexes.
Thus, Ago1/3/4-DPAZ maintained their ability to physically
associate with small-RNA duplexes, but not the ability to
unwind and form active RISC.
HsAgo2-DPAZ RISC Achieved Activation by Eliminating
the Passenger Strand through its Residual Slicer Activity
Because the PAZ domain was critical for the Agos’ unwinding
of the guide-passenger duplex RNAs, we wanted to establish
whether the generation of active Ago2-DPAZ-RISC complexes
(Figure 1D) was solely dependent on its residual slicer
activity. To test this idea, we generated a double mutation
of Ago2 deficient in both slicer activity and the PAZ domain
(DPAZ-D5).As expected, introducing a single-
point mutation to abolish the slicer
activity did not change the binding
affinity of Ago2-DPAZ. Guide strands
of sh-miR30 and sh-miR30-B were
pulled down by DPAZ-D5 with a similar
efficiency to that obtained by Ago2-
DPAZ (Figure 3A). However, DPAZ-D5
was unable to enhance gene repression
in a complementation assay (Figures 3B
and S3), suggesting thatDPAZ-D5-RISC
was functionally inactive even though it
maintained its ability to bind small
duplex RNAs.To test whether the failure of DPAZ-D5 tomediate transgene
repression was indeed due to its inability to unwind RNA
duplexes, we analyzed the Ago-IP samples with a native gel
and directly assessed the ratio between single-stranded
RNA (ssRNA)-associated RISC and double-stranded RNA
(dsRNA)-associated RISC. Consistent with our hypothesis,
guide strands processed from sh-miR30 and sh-miR30-B
were mainly associated with DPAZ-D5 as duplex RNAs (Fig-
ure 3C). Interestingly, extremely few, if any, ssRNA-associated
Ago2-DPAZ was detected, indicating that the activation of
Ago2-DPAZ into an active RISC was rather inefficient (Fig-
ure 3C). This was consistent with the idea that the only
pathway available for Ago2-DPAZ to achieve activation was
cleavage of the passenger strand through its inefficient slicer
activity.
Notably, whereas ssRNA-associated mature Ago2-DPAZ-
RISC was almost undetectable in the native gel (Figure 3C),
the level of noncleavage repression mediated by Ago2-
DPAZ-RISC was similar and comparable to Ago2-D5-RISC
and Ago2-DPAZ-RISC (Figure 3B). Similar results were found
whenwe tested shRNAswith a different sequence (sh-Bantam)
(Figure S3). Our results suggest that, once successfully loaded
Figure 3. Ago2-DPAZ-Forming Mature RISC
through a Slicer-Dependent Pathway
(A) Sh-miR30 or shRNA-miR30-B coexpressed
with Flag-GFP or various Flag-Ago2 mutants in
Ago2 KO MEF cells. IP and northern blotting
experiments were performed as described in Fig-
ure 1. The expression levels of the proteins used
in the assays were assessed by western blotting
with Ago2 antibody. Signals from GAPDH served
as transfection and loading controls.
(B) A psiCHECK vector with four tandem target
sites in the 30 UTR, which were mismatched to
the guide strand of sh-miR30 and sh-miR30-B,
was cotransfected with various shRNAs and
Argonaute-expressing plasmids in Ago2 KO
MEF cells. Dual-luciferase assays were per-
formed and analyzed as described in Figure 1.
Error bars represent the SD from two indepen-
dent experiments, each performed in triplicate
transfections.
(C) IP samples in (A) were separated on 15%
polyacrylamide native gels. 20 fmol synthetic
RNAs (si-miR30 duplex and single-stranded
guide-strand RNA of miR-30) were also loaded
on the gel as controls. Guide- and passenger-
strand RNAs were identified by sequential
northern blot. Notably, the si-miR30 control ran
as a mixture of dsRNA and a trace amount of
ssRNA. See also Figure S3.
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1539with a guide-strand ssRNA, the repressive ability of an indi-
vidual Ago2-DPAZ was actually greater than its wild-type
counterpart. At this point, the mechanism of the Ago2-DPAZ
hyperactivity is unclear. One possible scenario is that the
30 portion of the guide strand is able to precipitate and
strengthen the guide-target hybridization when freed from
PAZ-domain binding. Therefore, the enhanced ability of
Ago2-DPAZ-RISC to mediate noncleavage repression is the
result of a more stable interaction between RISC and target
messenger RNAs.
HsAgo2 with Point Mutations in PAZ Is Defective in Slicer-
Independent RISC Unwinding
To confirm that the deficiency in RISC activation was specific
to the function of the PAZ domain, but not secondary to gross
structural changes caused by the deletion of the whole
domain, we created Ago2 variants with a series of point muta-
tions in the PAZ domain. PAZ8 and PAZ9 contain eight or nine
point mutations, respectively, which are involved in PAZ-
siRNA association [9, 12, 18]. Similar to what we found using
the PAZ-deleted Ago2 truncations, both Ago2-PAZ8 and
Ago2-PAZ9 and their slicer-deficient counterparts (PAZ8-D5and PAZ9-D5) were able to associate,
albeit less efficiently than wild-type
Ago2, with small RNAs processed from
sh-miR30 and sh-miR30-B (Figure 4A).
However, only Ago2-PAZ8 and Ago2-
PAZ9, but not PAZ8-D5 and PAZ9-D5,
were capable of inducing transgene
silencing in the reporter assay (Figures
4B and S4). The native-gel analysis
further confirmed that the failure of
PAZ8-D5 and PAZ-D5 to mediate non-
cleavage repression was due to their
inability to unwind RNA duplexes (Fig-
ure 4C). Taken together, these resultsstrongly suggest that the PAZ-small RNA association is critical
for RISC maturation.
HsAgo2 with PAZ Domain Mutations Is Deficient in
Unwinding of Endogenous miRNAs
To study the RISC unwinding of endogenous miRNAs, we
deep sequenced the Ago-associated small RNAs (IP samples)
and measured the amount of each detectable miRNA and its
corresponding star strands in HEK293 cells. Consistent with
our previous results using shRNA expression sequences, the
average percentage of endogenous star strands was sig-
nificantly higher (p < 0.05) in PAZ-domain mutations (Ago2-
DPAZ and Ago2-PAZ8) than in wild-type Ago2 controls
(Figure 4D), further supporting their inability to unwind duplex
RNAs. Interestingly, the slicer-defective PAZ mutants (DPAZ-
D5 and PAZ8-D5) had an even higher average percentage of
star strands, suggesting a role of slicer activity in Ago2 loading
of miRNAs (Figure S4C). On average, the miRNAs behaved
similarly to the shRNAs, whereas some of the individual
miRNAs did not. For example, DPAZ-D5 blocked the un-
winding of hsa-miR-17 and hsa-miR-424 but had marginal
effects on hsa-miR-15b and hsa-miR-9 (Table 1), suggesting
Figure 4. Ago2 with Point Mutations in PAZ Is Defective in Slicer-Independent RISC Unwinding
(A) Sh-miR30 or shRNA-miR30-B coexpressed with Flag-GFP or various Flag-Ago2 mutants in Ago2 KO MEF cells. IP and northern blotting experiments
were performed as described in Figure 1. The expression levels of the proteins used in the assays were assessed by western blotting with Ago2 antibody.
The signal from GAPDH served as the transfection and loading controls.
(B) A psiCHECK vector with four tandem target sites in the 30 UTR, which were mismatched to the guide strand of sh-miR30 and sh-miR30-B, was cotrans-
fected with various shRNAs and Argonaute-expressing plasmids in Ago2 KOMEF cells. Dual-luciferase assays were performed and analyzed as described
in Figure 1. Error bars represent the SD from two independent experiments, each performed in triplicate transfections.
(C) IP samples in (A) were separated on 15% polyacrylamide native gels. 20 fmol synthetic RNAs (si-miR30 duplex and single-stranded guide-strand RNA of
miR-30) were also loaded on the gel as controls. Guide- and passenger-strand RNAs were identified by sequential northern blot. Notably, the si-miR30
control ran as a mixture of dsRNA and a trace amount of ssRNA.
(D) The amount of miRNAs and their corresponding star strands were measured in various Ago-IP samples by deep sequencing. For each miRNA, the
percentage of its star strand to total reads was determined. The weighted average and SD were calculated by using the total reads of each miRNA as
the weight. Number sign (#) indicates statistical significance (p < 0.05, unpaired t test, using Ago2-IP as a control group). See also Figure S4 and Table S1.
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1540the presence of additional RISC-assembling pathway(s) spe-
cific to miRNA subgroups.
A Proposed Model for Slicer-Independent RISC Unwinding
Our observations raised intriguing questions regarding the
mechanism(s) involved in the slicer-independent unwinding
pathway and the requirement for the PAZ domain in this pro-
cess. In light of published results [6, 14, 19–23] and the data
presented here, we propose a modified model for slicer-
independent unwinding (Figure S5A). In brief, the Agos
undergo a conformational change involving the movement of
the PAZ domain during the loading of duplex RNAs. During
this transition, the PAZ domain will tightly associate with the
30 end of the guide strand and function as a handle to peel
off the duplex (see Supplemental Discussion for details).
A recent report indicated that the N domain was involved in
duplex unwinding [24]. To compare the contributions of thePAZ and N domains directly, we tested two of these N-domain
mutants, Ago2-DWedge (truncation) and Ago2-F181A (point
mutation) [24]. Unlike the PAZ mutations, both N-domain
mutants and their corresponding slicer-defective versions
(DWedge-D5 and F181A-D5) were still able to unwind the
unstable sh-miR-30-B (Figure S5B). This conclusion was fur-
ther supported by the observation that all N-domain mutants
could induce transgene silencing, albeit some (Ago2-DWedge
and DWedge-D5) were less efficient than wild-type Ago2
(Figures S5C and S5D). The apparent contradiction could be
explained by the difference in the method used to measure
the RISC activation. Although the N-domain study [24] mea-
sured the changes in the unwinding rate in the first 30 min of
RISC formation in a reconstitution system, our analysis was
performed in living cells under steady-state conditions (24 hr
posttransfection) and suggests that this domain is not essen-
tial for unwinding. It is possible that the N domain is involved in
Table 1. Ago2 Variants with PAZ-Domain Mutations Are Defective in Unwinding of Endogenous miRNAs in HEK293 Cells
Ago2 Ago2-D5 Ago2-DPAZ DPAZ-D5 Ago2-PAZ8 PAZ8-D5 F181A
Hsa-miR-17 13.07% 18.44% (1.4) 38.03% (2.9) 49.23% (3.8) 17.36% (1.3) 35.13% (2.7) 15.15% (1.2)
Hsa-miR-15b 0.69% 0.51% (0.7) 0.67% (1.0) 0.68% (1.0) 0.88% (1.3) 0.95% (1.4) 0.95% (1.4)
Hsa-miR-221 0.12% 0.13% (1.1) 0.05% (0.5) 0.74% (6.2) 0.39% (3.3) 1.18% (9.8) 0.14% (1.2)
Hsa-miR-20a 2.81% 3.19% (1.1) 4.49% (1.6) 8.00% (2.8) 7.65% (2.7) 31.88% (11.3) 2.83% (1.0)
Hsa-miR-106b 26.67% 24.72% (0.9) 27.03% (1.0) 38.46% (1.4) 58.62% (2.2) 47.87% (1.8) 34.48% (1.3)
Hsa-miR-15a 1.82% 5.566% (3.1) 16.92% (9.3) 9.09% (5.0) 8.33% (4.6) 5.12% (2.8) 3.19% (1.8)
Hsa-miR-126 19.44% 30.16% (1.6) 29.29% (1.5) 25.00% (1.3) 25.00% (1.3) 27.16% (1.4) 17.65% (0.9)
Hsa-miR-424 8.33% 10.77% (1.3) 39.58% (4.8) 41.67% (5.0) 7.50% (0.9) 48.15% (5.8) 7.46% (0.9)
Hsa-miR-9 10.53% 30.51% (2.9) 18.37% (1.7) 18.18% (1.7) 34.37% (3.3) 19.44% (1.8) 9.26% (0.9)
Hsa-miR-183 12.50% 29.17% (2.3) 69.23% (5.5) 66.67% (5.3) 18.75% (1.5) 68.18% (5.5) 15.00% (1.2)
The abundance of miRNAs and their corresponding star strands were measured in various immunoprecipitated (IP) Ago samples by deep sequencing. For
each miRNA, the percentage of its star strands to total reads was determined. Results of ten miRNAs with both guide and passenger strands detected are
listed here, and the weighted average of each sample is presented in Figure S4C. The higher the percentage of star strands in the IP sample, the bigger the
unwinding defects of Ago2 variants. The relative fold of star-strand percentage to the wild-type Ago2 control is indicated by the number inside the
parentheses.
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1541the initiation of the unwinding process and only affects the
efficiency of the process. Consistent with this idea, our
deep-sequencing analyses found that the N-domain mutation
(Ago2-F181A) had a smaller impact on endogenous-miRNA
unwinding than PAZ-domain mutations did (Figure S4C and
Table 1). Whether or not this quantitative difference is due to
the fact that the N-domain mutants may affect the structural
integrity of the PAZ domain is not clear.
Overall, we defined an additional role for the Ago PAZ
domain in the mammalian RNAi pathway. Our studies provide
working models for how this domain fits into the biology of
small-duplex-RNA-mediated gene silencing. Moreover, our
findings suggest that siRNAs and shRNAs require the pres-
ence of an interaction with the PAZ domain to form mature
RISC with noncleaving Agos, offering a way to design si/
shRNAs that would preferentially be loaded into cleaving
Agos. This provides insights into how to devise potent si/
shRNAs with minimal off-target effects for therapeutic
applications.
Accession Numbers
The NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/)
accession number for the sequence reported in this paper is GSE39146.
Supplemental Information
Supplemental Information includes five figures, Supplemental Discussion,
and Supplemental Experimental Procedures and can be found with this
article online at http://dx.doi.org/10.1016/j.cub.2012.06.040.
Acknowledgments
We thank Michael M. Pan for technical assistance and Greg Hannon for the
MEF Ago 2 KO cells. This work was supported by NIH DK078424.
Received: March 2, 2012
Revised: April 17, 2012
Accepted: June 12, 2012
Published online: July 12, 2012
References
1. Carthew, R.W., and Sontheimer, E.J. (2009). Origins andMechanisms of
miRNAs and siRNAs. Cell 136, 642–655.
2. Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and
function. Cell 116, 281–297.
3. Malone, C.D., and Hannon, G.J. (2009). Small RNAs as guardians of the
genome. Cell 136, 656–668.4. Siomi, H., and Siomi, M.C. (2009). On the road to reading the RNA-inter-
ference code. Nature 457, 396–404.
5. Czech, B., and Hannon, G.J. (2011). Small RNA sorting: matchmaking
for Argonautes. Nat. Rev. Genet. 12, 19–31.
6. Kawamata, T., and Tomari, Y. (2010). Making RISC. Trends Biochem.
Sci. 35, 368–376.
7. Hutvagner, G., and Simard, M.J. (2008). Argonaute proteins: key players
in RNA silencing. Nat. Rev. Mol. Cell Biol. 9, 22–32.
8. Peters, L., andMeister, G. (2007). Argonaute proteins: mediators of RNA
silencing. Mol. Cell 26, 611–623.
9. Ma, J.B., Ye, K., and Patel, D.J. (2004). Structural basis for overhang-
specific small interfering RNA recognition by the PAZ domain. Nature
429, 318–322.
10. Lingel, A., Simon, B., Izaurralde, E., and Sattler, M. (2004). Nucleic acid
30-end recognition by the Argonaute2 PAZ domain. Nat. Struct. Mol.
Biol. 11, 576–577.
11. Wang, Y., Sheng, G., Juranek, S., Tuschl, T., and Patel, D.J. (2008).
Structure of the guide-strand-containing argonaute silencing complex.
Nature 456, 209–213.
12. Yan, K.S., Yan, S., Farooq, A., Han, A., Zeng, L., and Zhou, M.M. (2003).
Structure and conserved RNA binding of the PAZ domain. Nature 426,
468–474.
13. Song, J.-J., Liu, J., Tolia, N.H., Schneiderman, J., Smith, S.K.,
Martienssen, R.A., Hannon, G.J., and Joshua-Tor, L. (2003). The crystal
structure of the Argonaute2 PAZ domain reveals anRNAbindingmotif in
RNAi effector complexes. Nat. Struct. Biol. 10, 1026–1032.
14. Gu, S., Jin, L., Zhang, F., Huang, Y., Grimm,D., Rossi, J.J., and Kay, M.A.
(2011). Thermodynamic stability of small hairpin RNAs highly influences
the loading process of different mammalian Argonautes. Proc. Natl.
Acad. Sci. USA 108, 9208–9213.
15. Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song,
J.J., Hammond, S.M., Joshua-Tor, L., and Hannon, G.J. (2004).
Argonaute2 is the catalytic engine of mammalian RNAi. Science 305,
1437–1441.
16. Su, H., Trombly, M.I., Chen, J., and Wang, X. (2009). Essential and over-
lapping functions for mammalian Argonautes in microRNA silencing.
Genes Dev. 23, 304–317.
17. Wang, Y., Juranek, S., Li, H., Sheng, G., Tuschl, T., and Patel, D.J. (2008).
Structure of an argonaute silencing complex with a seed-containing
guide DNA and target RNA duplex. Nature 456, 921–926.
18. Liu, J., Valencia-Sanchez, M.A., Hannon, G.J., and Parker, R. (2005).
MicroRNA-dependent localization of targeted mRNAs to mammalian
P-bodies. Nat. Cell Biol. 7, 719–723.
19. Wang, Y., Juranek, S., Li, H., Sheng, G., Wardle, G.S., Tuschl, T., and
Patel, D.J. (2009). Nucleation, propagation and cleavage of target
RNAs in Ago silencing complexes. Nature 461, 754–761.
20. Miyoshi, T., Takeuchi, A., Siomi, H., and Siomi, M.C. (2010). A direct role
for Hsp90 in pre-RISC formation in Drosophila. Nat. Struct. Mol. Biol. 17,
1024–1026.
21. Iwasaki, S., Kobayashi, M., Yoda, M., Sakaguchi, Y., Katsuma, S.,
Suzuki, T., and Tomari, Y. (2010). Hsc70/Hsp90 chaperone machinery
mediates ATP-dependent RISC loading of small RNA duplexes. Mol.
Cell 39, 292–299.
Current Biology Vol 22 No 16
154222. Iki, T., Yoshikawa, M., Nishikiori, M., Jaudal, M.C., Matsumoto-
Yokoyama, E., Mitsuhara, I., Meshi, T., and Ishikawa, M. (2010).
In vitro assembly of plant RNA-induced silencing complexes facilitated
by molecular chaperone HSP90. Mol. Cell 39, 282–291.
23. Johnston, M., Geoffroy, M.C., Sobala, A., Hay, R., and Hutvagner, G.
(2010). HSP90 protein stabilizes unloaded argonaute complexes and
microscopic P-bodies in human cells. Mol. Biol. Cell 21, 1462–1469.
24. Kwak, P.B., and Tomari, Y. (2012). The N domain of Argonaute drives
duplex unwinding during RISC assembly. Nat. Struct. Mol. Biol. 19,
145–151.
